Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder.

Harkness KL, Bagby RM, Kennedy SH.

J Consult Clin Psychol. 2012 Jun;80(3):342-53. doi: 10.1037/a0027665. Epub 2012 Mar 19.

PMID:
22428942
2.

Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

Segal ZV, Kennedy S, Gemar M, Hood K, Pedersen R, Buis T.

Arch Gen Psychiatry. 2006 Jul;63(7):749-55.

PMID:
16818864
3.

Childhood maltreatment and migraine (part I). Prevalence and adult revictimization: a multicenter headache clinic survey.

Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA.

Headache. 2010 Jan;50(1):20-31. doi: 10.1111/j.1526-4610.2009.01556.x. Epub 2009 Oct 21.

PMID:
19845782
4.

Symptom specificity in the acute treatment of Major Depressive Disorder: a re-analysis of the treatment of depression collaborative research program.

Stewart JG, Harkness KL.

J Affect Disord. 2012 Mar;137(1-3):87-97. doi: 10.1016/j.jad.2011.12.015. Epub 2012 Jan 16.

PMID:
22252094
5.

Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.

Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, Gallop R, McGlinchey JB, Markley DK, Gollan JK, Atkins DC, Dunner DL, Jacobson NS.

J Consult Clin Psychol. 2006 Aug;74(4):658-70.

PMID:
16881773
6.
7.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

8.

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.

Parikh SV, Segal ZV, Grigoriadis S, Ravindran AV, Kennedy SH, Lam RW, Patten SB; Canadian Network for Mood and Anxiety Treatments (CANMAT).

J Affect Disord. 2009 Oct;117 Suppl 1:S15-25. doi: 10.1016/j.jad.2009.06.042. Epub 2009 Aug 13.

PMID:
19682749
9.

Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.

Maina G, Rosso G, Bogetto F.

J Affect Disord. 2009 Apr;114(1-3):200-7. doi: 10.1016/j.jad.2008.07.010. Epub 2008 Aug 26.

10.

Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).

Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH.

J Clin Psychiatry. 2009 Feb;70(2):232-7. Epub 2009 Jan 13.

PMID:
19192459
11.

Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.

Schramm E, Schneider D, Zobel I, van Calker D, Dykierek P, Kech S, Härter M, Berger M.

J Affect Disord. 2008 Jul;109(1-2):65-73. Epub 2007 Dec 11.

PMID:
18067973
12.

Prevalence and risk factors for recurrence of depression five years after short term psychodynamic therapy.

Koppers D, Peen J, Niekerken S, Van R, Dekker J.

J Affect Disord. 2011 Nov;134(1-3):468-72. doi: 10.1016/j.jad.2011.05.027. Epub 2011 Jun 15.

PMID:
21676466
13.

Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up.

Martinsen EW, Olsen T, Tønset E, Nyland KE, Aarre TF.

J Clin Psychiatry. 1998 Aug;59(8):437-42; quiz 443.

PMID:
9721829
14.

Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study.

Bockting CL, Spinhoven P, Wouters LF, Koeter MW, Schene AH; DELTA Study Group.

J Clin Psychiatry. 2009 Dec;70(12):1621-8. doi: 10.4088/JCP.08m04784blu.

PMID:
20141705
15.

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.

J Clin Psychopharmacol. 2002 Oct;22(5):474-80.

PMID:
12352270
16.

Depressive personality and treatment outcome in major depressive disorder.

Ryder AG, Quilty LC, Vachon DD, Bagby RM.

J Pers Disord. 2010 Jun;24(3):392-404. doi: 10.1521/pedi.2010.24.3.392.

PMID:
20545502
17.

Psychodramatic psychotherapy combined with pharmacotherapy in major depressive disorder: an open and naturalistic study.

Costa EM, Antonio R, Soares MB, Moreno RA.

Rev Bras Psiquiatr. 2006 Mar;28(1):40-3. Epub 2006 Mar 24.

18.

Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.

Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D, Kraemer J.

J Affect Disord. 2002 Apr;68(2-3):317-30.

PMID:
12063159
19.

Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).

Lewis CC, Simons AD, Nguyen LJ, Murakami JL, Reid MW, Silva SG, March JS.

J Am Acad Child Adolesc Psychiatry. 2010 Feb;49(2):132-40.

PMID:
20215935
20.

Adaptation of dialectical behavior therapy skills training group for treatment-resistant depression.

Harley R, Sprich S, Safren S, Jacobo M, Fava M.

J Nerv Ment Dis. 2008 Feb;196(2):136-43. doi: 10.1097/NMD.0b013e318162aa3f.

PMID:
18277222

Supplemental Content

Support Center